Release of AST, ALT, and LDH was remarkably reduced in the UTI preservation solution (LR + UTI) group and the combined UTI preservation plus recipient UTI administration (LR + UTI + RT) group compared to the LR control group (P < 0.05). This evidence concerns the gene GPT and bacterial urinary tract infection.